HNW
EW icon

High Note Wealth’s Edwards Lifesciences EW Stock Holding History

High Note Wealth’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.12K Buy
39
+8
+26% +$660 ﹤0.01% 698
2025
Q4 		$2.64K Sell
31
-20
-39% -$1.64K ﹤0.01% 693
2025
Q3 		$3.97K Sell
51
-50
-50% -$3.91K ﹤0.01% 568
2025
Q2 		$7.9K Sell
101
-5
-5% -$373 ﹤0.01% 328
2025
Q1 		$7.68K Sell
106
-2
-2% -$143 ﹤0.01% 324
2024
Q4 		$8K Buy
+108
New +$7.56K ﹤0.01% 326

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

High Note Wealth's EW Position: Q1 2026 in Review

High Note Wealth increased its Edwards Lifesciences (EW) stake by 26% in Q1 2026, buying an estimated $660 and bringing the position to 39 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #698.

High Note Wealth first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $8K in Q4 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • High Note Wealth held 39 shares of Edwards Lifesciences worth $3.12K as of Q1 2026.
  • High Note Wealth bought 8 Edwards Lifesciences shares in Q1 2026, an estimated $660.
  • Edwards Lifesciences made up ﹤0.01% of High Note Wealth's portfolio in Q1 2026, its #698 holding.
  • High Note Wealth first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • High Note Wealth's Edwards Lifesciences position peaked at $8K in Q4 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on High Note Wealth's 13F filing for Q1 2026, filed 11 May 2026.